Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia
•Early identification of pregnancies at risk for preeclampsia is a challenge in modern obstetrics.•Circulating relaxin is emerging as an important regulator of maternal vascular adaptations to pregnancy.•Late-onset preeclampsia is associated with low relaxin levels in the 1st trimester of pregnancy....
Gespeichert in:
Veröffentlicht in: | Pregnancy hypertension 2020-10, Vol.22, p.47-53 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Early identification of pregnancies at risk for preeclampsia is a challenge in modern obstetrics.•Circulating relaxin is emerging as an important regulator of maternal vascular adaptations to pregnancy.•Late-onset preeclampsia is associated with low relaxin levels in the 1st trimester of pregnancy.•Particularly late-onset preeclampsia combined with a small for gestational age infant.
Preeclampsia, a multi-system hypertensive disorder, is associated with perturbations in the maternal cardiovascular system during early pregnancy. The corpus luteal hormone relaxin, a potent vasodilator, may contribute to physiological circulatory changes especially in early gestation when circulating levels are highest. This study investigated whether first trimester circulating relaxin may be a suitable biomarker for the early prediction of preeclampsia.
Relaxin was initially measured in first-trimester samples of women who developed late-onset preeclamptic (LO-PE; delivery ≥ 34 weeks; n = 33) and uncomplicated pregnancies (n = 25) in Pittsburgh, USA. Subsequently, to expand the group numbers, relaxin was measured in women who developed LO-PE (n = 95), early-onset preeclamptic (EO-PE; delivery |
---|---|
ISSN: | 2210-7789 2210-7797 |
DOI: | 10.1016/j.preghy.2020.07.008 |